Observation on the effects of needle-embedding therapy combined with Western medication on sleep quality, emotional state, and prognosis in patients with depression accompanied by insomnia
摘要
To observe the effects of needle-embedding therapy combined with Western medication on sleep quality, emotional state, and prognosis in patients with depression accompanied by insomnia.
MethodsA total of 50 patients with depression and insomnia treated between April 2019 and April 2020 were assigned to a medication group, and another 50 patients treated between May 2020 and May 2021 were assigned to a combination group. Both groups were treated with oral venlafaxine, while the combination group additionally received needle-embedding therapy. Traditional Chinese Medicine (TCM) symptom scores (excessive thinking and worrying, fatigue and weakness, and sleeplessness with irritability), sleep quality [Pittsburgh sleep quality index (PSQI)], and emotional state [17-item Hamilton depression scale (HAMD-17)] were compared between the two groups before treatment and after 2 weeks of treatment. Adverse reactions during treatment were recorded. Clinical efficacy was compared after treatment, and insomnia recurrence and readmission rates were observed 3 months after treatment.
ResultsAfter 2 weeks of treatment, TCM symptom scores, PSQI, and HAMD-17 scores in both groups were significantly lower than those before treatment (P<0.05), and all scores in the combination group were significantly lower than those in the medication group (P<0.05). The total effective rate in the combination group was significantly higher than that in the medication group (P<0.05). No significant adverse reactions occurred in either group during treatment. Within 3 months after treatment, the recurrence rate of insomnia and the readmission rate were significantly lower in the combination group than in the medication group (P<0.05).
ConclusionNeedle-embedding therapy combined with oral venlafaxine is superior to venlafaxine alone in alleviating clinical symptoms and improving emotional states in patients with depression accompanied by insomnia, showing better short-term and long-term efficacy.